NIFTY 50

Pharma earnings preview: Q2 likely to be subdued due to regulatory concerns

Updated : October 11, 2019 05:57 PM IST

Q2FY20 earnings are likely to moderate after three-quarters of a continuous uptrend
Sales are estimated to grow from 9 to 12 percent
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV